Squamous cell carcinoma of the anal canal and anal margin

Hematology/Oncology Clinics of North America

Volumn 15, Issue 2, 2001, Pages 321-344

  Chawla, Ashish K ^b   Willett, Christopher G ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS CARCINOMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CARDIOTOXICITY; CIGARETTE SMOKING; CLINICAL TRIAL; DIARRHEA; DISEASE COURSE; DRUG INDUCED DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NAUSEA; ORGAN PRESERVATION; PAPILLOMA VIRUS; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURGICAL ANATOMY; TREATMENT OUTCOME; TUMOR VOLUME; VOMITING;

EID: 0035031219     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70215-X     Document Type: Article

References (88)

1. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy
2. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups
3. Carcinoma of the anus
4. Cancer in a group at risk of acquired immunodeficiency syndrome (AIDS) through 1984
5. Carcinoma of the anal canal: A clinical and pathologic study of 188 cases
6. Relationship of chronic anorectal disease to carcinoma
7. Combined therapy for cancer of the anal canal: A follow-up report
8. Interaction of human immunodeficiency and papilloma viruses: Association with anal epithelial abnormality in homosexual men
9. Squamous-cell carcinoma of the anus in HIV-positive patients
10. Treatment of unresectable adenocarcinoma of the stomach with a combination of 5-fluorouracil and radiation
11. Epidermoid carcinoma of the anal canal
12. Computed tomography of epithelial neoplasms of the anal canal
13. Time-dose considerations in the treatment of anal cancer
14. Treatment of perianal carcinoma by radiation (RT) or radiation plus chemotherapy (RTCT)
15. Epidermoid anal cancer: Treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C
16. Cigarette smoking and the risk of anogenital cancer
17. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer
18. Correlates of homosexual behavior and the incidence of anal cancer
19. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: Results in 35 consecutive patients
20. Carcinoma of the anal canal: A study of 79 cases
21. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus
22. Improved survival in epidermoid carcinoma of the anus in association with preoperative multidisciplinary therapy
23. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study
24. The potentiation of radiation effects with 5-fluorouracil
25. Sexually transmitted infection as a cause of anal cancer
26. Trends in incidence of anal cancer in Denmark
27. Benign anal lesions and the risk of anal cancer
28. Malignancies that occur before and after anal cancer: Clues to their etiology
29. Epidermoid cancer of the anorectum
30. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men
31. Prognostic significance of clinical stage, histologic grade, and nuclear DNA content in squamous-cell carcinoma of the anus
32. Recurrent epidermoid cancer of the anus
33. Epidermoid cancer of the anal margin: Pathologic features, treatment, and clinical results
34. Treatment of epidermoid carcinoma of the anal canal
35. Cancer statistics, 1999
36. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer
37. Anal cancer incidence: Genital warts, anal fissure or fistula, hemorrhoids, and smoking
38. 30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy
39. Radiotherapy for anal cancer: Experience from 1979-1987
40. Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal
41. Dose escalation without split-course chemoradiation for anal cancer: Results of a phase II RTOG study
42. Dose acceleration in chemoradiation for anal cancer: Preliminary results of RTOG 9208
43. Epidermoid carcinoma of the perianal skin and anal canal
44. External radiation therapy without chemotherapy in the management of anal cancer
45. Results of combined modality therapy for patients with anal cancer (E7283): An Eastern Cooperative Oncology Group study
46. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): An Eastern Cooperative Oncology Group study
47. Changing patterns of anal cancer incidence in the United States, 1940-1989
48. Squamous cell carcinoma of the anal margin treated with radiotherapy
49. Preoperative chemotherapy and radiation therapy in the management of anal epidermoid carcinoma
50. Treatment of squamous cell carcinoma of the anal canal
51. The pathology and results of treatment of squamous cell carcinoma of the anal canal and anal margin
52. Carcinoma of the anal canal
53. Combined therapy for cancer of the anal canal: A preliminary report
54. Burn scar carcinoma: A review and analysis of 46 cases
55. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer
56. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: Prevalence and risk factors
57. Respective roles of radiotherapy and surgery in the management of epidermoid carcinoma of the anal margin: Series of 57 patients
58. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal
59. Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: A French cooperative study
60. Cancers of the anogenital region in renal transplant recipients: Analysis of 65 cases
61. Parallels in the epidemiology of selected anogenital carcinomas
62. Carcinoma of the anus in Crohn's disease
63. Second primary cancers following anal and cervical carcinoma: Evidence of shared etiologic factors
64. Chemoradiation therapy for anal cancer: Radiation plus continuous infusion of 5-fluorouracil with or without cisplatin
65. Carcinoma of the anal canal
66. Treatment of epidermoid anal canal cancer
67. Carcinoma of the anal canal and flow cytometric analysis
68. Cancer death rates associated with human immunodeficiency virus infection in the United States
69. Cancer of the anal region
70. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma
71. Prognostic factors in anal squamous carcinoma: A multivariate analysis of clinical, pathological, and flow cytometric parameters in 235 cases
72. Anogenital papillomavirus infection and neoplasia in immunodeficient women: An update
73. Malignant epithelial tumors of the anal canal
74. Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: Interim report on Radiation Therapy Oncology Group study no. 8314
75. Anal carcinoma in patients with Crohn's disease
76. Cancer of the anal cancer
77. Conservative versus nonconservative treatment of epidermoid carcinoma of the anal canal for tumors longer than or equal to 5 centimeters: A retrospective comparison
78. Epidermoid carcinoma of the anal canal: Results of curative-intent radiation therapy in a series of 270 patients
79. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
80. Mitomycin C-induced renal toxicity, a dose-dependent side effect?
81. Prospective study on the dose relationship of mitomycin C-induced interstitial pneumonitis
82. Smoking and cervical cancer - Current status: A review
83. The management of metastatic inguinal adenitis in epidermoid cancer of the anus
84. Surveillance, epidemiology, and end results: Incidence and mortality data, 1973-77
85. Human papillomavirus infection and anal carcinoma: Retrospective analysis by in situ hybridization and the polymerase chain reaction
86. Results of abdominoperineal resections for failures after combination chemotherapy and radiation therapy for anal canal cancers